How the MTHFR Gene Affects Vitamin Processing from Food
The MTHFR gene produces an enzyme that converts dietary folate (vitamin B9) into its active form, 5-methyltetrahydrofolate (5-MTHF), which your body needs to process the amino acid homocysteine and maintain proper methylation reactions throughout the body. 1
The Core Metabolic Function
The MTHFR enzyme sits at a critical junction in folate metabolism, performing a specific biochemical transformation:
MTHFR catalyzes the irreversible conversion of 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate (5-MTHF), which is the predominant circulating form of folate in your bloodstream 2, 3
5-MTHF serves as the methyl donor for converting homocysteine back to methionine, a reaction that requires vitamin B12 (as methylcobalamin) as a cofactor and is catalyzed by the enzyme methionine synthase 4, 2
This conversion is essential because methionine is needed to produce S-adenosyl-methionine (SAM), which drives hundreds of methylation reactions in your cells, including DNA methylation, protein modification, and neurotransmitter synthesis 4
The Vitamin B Interdependence
MTHFR function reveals how tightly interconnected B-vitamin metabolism really is:
Vitamin B2 (riboflavin) is required as a cofactor for MTHFR enzyme activity itself, meaning inadequate riboflavin directly impairs the enzyme's ability to produce active folate 4, 2
Vitamin B6 is needed upstream to help convert tetrahydrofolate (THF) to 5,10-methylenetetrahydrofolate through the enzyme serine hydroxymethyltransferase, and downstream in the transsulfuration pathway where homocysteine is converted to cysteine via cystathionine β-synthase 4, 2
Vitamin B12 deficiency creates a "folate trap" where 5-MTHF accumulates because methionine synthase cannot function without B12, preventing the regeneration of tetrahydrofolate and effectively creating a functional folate deficiency even when folate intake is adequate 1, 2
Common MTHFR Gene Variants and Their Impact
The most clinically significant variant affects how efficiently your body processes folate:
The C677T polymorphism is carried by 30-40% of people as heterozygotes (CT) and 10-15% as homozygotes (TT), with the TT genotype producing a thermolabile enzyme with significantly reduced activity 1, 3
Homozygous TT carriers have reduced MTHFR enzyme activity, which leads to lower production of 5-MTHF and can result in elevated homocysteine levels, particularly when dietary folate, B12, or B6 intake is suboptimal 1, 5
The relationship between MTHFR genotype and homocysteine levels is strongly modified by B-vitamin status: TT homozygotes show the strongest correlation between serum folate and homocysteine, with 68.5% of homocysteine variation explained by B-vitamin status compared to only 20.6% in CC genotypes 5
Processing Synthetic vs. Natural Folate
A critical distinction exists between how your body handles folate from food versus supplements:
Dietary folate from leafy greens, legumes, and other whole foods enters as various folate forms that are more readily converted to active 5-MTHF through normal enzymatic pathways 1
Synthetic folic acid (found in fortified foods and most supplements) must first be reduced to dihydrofolate, then to tetrahydrofolate by the enzyme dihydrofolate reductase (DHFR) before it can enter the folate cycle 6, 2
This initial DHFR-dependent reduction is the rate-limiting step and can become saturated with high-dose folic acid supplementation, especially in individuals with below-average DHFR activity 2
A common 19-base-pair deletion in the DHFR gene occurs in approximately 29.5% of people as homozygous deletions, further impairing the conversion of synthetic folic acid to active forms 4
Clinical Consequences of Impaired MTHFR Function
When MTHFR activity is reduced, several metabolic problems can emerge:
Elevated homocysteine levels occur in many (though not all) individuals with TT genotype, particularly when B-vitamin intake is inadequate, and each 5 μmol/L rise in plasma homocysteine is associated with a 59% increase in stroke risk 1
The TT genotype confers a 2-3 fold increased risk for atherosclerotic vascular disease and stroke when hyperhomocysteinemia is present, with meta-analyses showing 26% higher odds of stroke in TT carriers 1
Impaired DNA synthesis and repair can occur because the conversion of 5,10-methylenetetrahydrofolate to 5-MTHF diverts folate away from thymidylate synthesis, which is needed to convert dUMP to dTMP for DNA production 7
Critical Pitfalls to Avoid
Several common mistakes can worsen outcomes in people with MTHFR variants:
Never supplement with folic acid alone without first checking vitamin B12 status, as folic acid can mask the hematologic manifestations of B12 deficiency (correcting anemia) while allowing irreversible neurological damage to progress 1, 2
Standard folic acid supplementation is less effective in TT homozygotes because it requires conversion by the deficient MTHFR enzyme; these individuals benefit more from direct 5-MTHF supplementation, which bypasses the enzymatic defect entirely 4, 1
Using cyanocobalamin instead of methylcobalamin or hydroxycobalamin is less effective for reducing homocysteine, as cyanocobalamin requires additional conversion steps to become metabolically active 4, 1
Focusing solely on folate while ignoring riboflavin is particularly problematic for TT homozygotes, as riboflavin is the essential cofactor that the already-impaired MTHFR enzyme requires to function 4, 1